Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.
Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Cancer Res. 2022 May 16;82(10):1849-1857. doi: 10.1158/0008-5472.CAN-21-3863.
Cancer is an evolutionary process that is characterized by the emergence of multiple genetically distinct populations or clones within the primary tumor. Intratumor heterogeneity provides a substrate for the selection of adaptive clones, such as those that lead to metastasis. Comparative molecular studies of primary tumors and metastases have identified distinct genomic features associated with the development of metastases. In this review, we discuss how these insights could inform clinical decision-making and uncover rational antimetastasis treatment strategies.
癌症是一个进化过程,其特征是原发性肿瘤内出现多个遗传上不同的群体或克隆。肿瘤内异质性为适应性克隆的选择提供了底物,例如导致转移的克隆。对原发性肿瘤和转移灶的比较分子研究已经确定了与转移发生相关的独特基因组特征。在这篇综述中,我们讨论了这些见解如何为临床决策提供信息,并揭示合理的抗转移治疗策略。